Generic Brands
Fewer generics enter market after linagliptin's patent expiry this August
When Sitagliptin went off patent, nearly 200 brands were vying for a share of the market
 "Fewer generics enter market after linagliptin's patent expiry this August")
Granules India gets USFDA nod for generic drug used to treat heartburn
Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Esomeprazole Magnesium delayed-release capsules indicated for short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease. The approval by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Esomeprazole Magnesium delayed-release capsules of strengths 20 mg and 40 mg, Granules India said in a regulatory filing. It is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Nexium Delayed-Release Capsules, 20 mg and 40 mg, of AstraZeneca Pharmaceuticals LP. Esomeprazole Magnesium capsules are indicated for short-term treatment of heartburn and other symptoms associated GERD, risk reduction of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults and long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison ...
 "Granules India gets USFDA nod for generic drug used to treat heartburn")
Ajanta Pharma hits 52-week high on upbeat branded generic business outlook
The management is confident to scale up margins again in the coming years on the back of enhanced contribution from Branded Generics business and normalisation of freight costs
 "Ajanta Pharma hits 52-week high on upbeat branded generic business outlook")
Best of BS Opinion: Italy locks down, branded generics market, and more
From why analysing state Budgets can be a challenging exercise to how the success of fact-checkers lies in the failure of journalism, here's a selection of Business Standard Opinion pieces for the day
 "Best of BS Opinion: Italy locks down, branded generics market, and more")
Branded generics: Uncertainty or opportunity?
The rules of the game in India's branded generics market are fuzzy to say the least
 "Branded generics: Uncertainty or opportunity?")
Here are top 20 generic drugs in India, anti-diabetic medicines top list
Analysts point out that options in generic-generic drugs for anti-diabetes is minimal
 "Here are top 20 generic drugs in India, anti-diabetic medicines top list")
